A critical step in the rejection process is the migration of anti-donor effector or memory T cells to the transplanted organ. Interrupting this step should prevent or weaken rejection, but safe clinical strategies to do so are not available. During the previous funding cycle we identified a key pathway by which anti-donor effector and memory T cells migrate to vascularized organ allografts. We demonstrated that donor antigen, presented by either graft endothelial cells or bone marrow-derived antigen presenting cells, is necessary and sufficient for the firm adhesion and trans-endothelial migration of anti-donor T cells. Signaling via G?i-coupled chemokine receptors was not required. In this grant renewal, we propose to investigate two novel aspects of antigen-driven T cell migration: (1) the role of graft antigen presenting cells, and (2) the role of TCR-triggered signaling pathways that cause T cell adhesion and transmigration. To accomplish these aims we will utilize heart and kidney mouse transplantation models, gene knockout mice in which antigen presentation or key signaling pathways are disrupted, and intravital imaging techniques that track migrating T cells in real time. The proposed studies are innovative and significant because they represent a shift from the classical, chemokine-dependent migration paradigm and provide novel opportunities for interrupting activated T cell migration in a specific and safe manner.
Despite significant improvement in short-term survival of organ transplants, rejection of transplanted organs remains a significant clinical problem. Identifying the mechanisms by which harmful immune cells, known as memory or effector T lymphocytes, enter and reject transplanted organs could lead to novel therapies that enhance long-term graft and patient survival after transplantation.
|Walch, Jeffrey M; Lakkis, Fadi G (2014) T-cell migration to vascularized organ allografts. Curr Opin Organ Transplant 19:28-32|
|Walch, Jeffrey M; Zeng, Qiang; Li, Qi et al. (2013) Cognate antigen directs CD8+ T cell migration to vascularized transplants. J Clin Invest 123:2663-71|
|Macedo, Camila; Walters, John T; Orkis, Elizabeth A et al. (2012) Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation 93:813-21|
|Oberbarnscheidt, Martin H; Walch, Jeffrey M; Li, Qi et al. (2011) Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3. Transplantation 91:827-32|
|Oberbarnscheidt, M H; Obhrai, J S; Williams, A L et al. (2010) Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells. Am J Transplant 10:162-7|
|Macedo, C; Orkis, E A; Popescu, I et al. (2009) Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 9:2057-66|
|Nasr, I W; Reel, M; Oberbarnscheidt, M H et al. (2007) Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant 7:1071-9|
|Obhrai, Jagdeep S; Oberbarnscheidt, Martin H; Hand, Timothy W et al. (2006) Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol 176:4051-8|
|Baddoura, Fady K; Nasr, Isam W; Wrobel, Barbara et al. (2005) Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 5:510-6|
|Nasr, Isam W; Wang, Yinong; Gao, Ge et al. (2005) Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol 174:6161-8|
Showing the most recent 10 out of 17 publications